Would you recommend use of ESA for anemia of kidney disease in the setting of metastatic solid tumor malignancy?

Topics: Medical Oncology • Anemia • Hematology • Benign Hematology • Solid organ malignancy • Chronic kidney disease • Nephrology

Answer from: at Academic Institution

It is not unreasonable in CKD patients with symptomatic anemia and a non-curable metastatic cancer to consider using an ESA. However, this requires an extensive discussion with the patient. ASCO/ASH guidelines recommend against the use of these agents in patients with curable malignancies, so if the...

Comments

at Kaiser Permanente, Los Angeles Med Center
Thank you so much, Dr. @Rakesh Mehta!

Medical Oncologist at Wentworth Douglass Hospital
Would you use it in a patient with recently resect...

at South Hills Nephrology Associates
I have had multiple discussions with oncology coll...

Related Questions